Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis.
Aldostefano PorcariMaddalena RossiFrancesco CappelliMarco CanepaBeatrice MusumeciAlberto CiprianiGiacomo TiniGiulia BarbatiGuerino Giuseppe VarràCristina MorelliCarlo FumagalliMattia ZampieriAlessia ArgiròPier Filippo VianelloEugenio SessaregoDomitilla RussoGiulio SinigianiLaura De MichieliGianluca Di BellaCamillo AutoreFederico PerfettoClaudio RapezziGianfranco SinagraMarco MerloPublished in: European journal of heart failure (2022)
In a large cohort of AL and ATTR-CA patients, 8.9% received a PM within 3 years after diagnosis. History of atrial fibrillation, PR >200 ms and QRS >120 ms predicted future PM implantation.
Keyphrases
- end stage renal disease
- atrial fibrillation
- mass spectrometry
- particulate matter
- multiple sclerosis
- air pollution
- ms ms
- newly diagnosed
- ejection fraction
- heavy metals
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- heart failure
- polycyclic aromatic hydrocarbons
- current status
- risk assessment
- percutaneous coronary intervention
- pulmonary embolism
- acute coronary syndrome
- mitral valve
- multiple myeloma
- patient reported